-
1
-
-
84873089194
-
Neuropsychiatric adverse events of varenicline: A systematic review of published reports
-
Ahmed AI, Ali AN, Kramers C, Harmark LV, Burger DM, Verhoeven WM, (2013). Neuropsychiatric adverse events of varenicline: a systematic review of published reports. J Clin Psychopharmacol 33: 55-62.
-
(2013)
J Clin Psychopharmacol
, vol.33
, pp. 55-62
-
-
Ahmed, A.I.1
Ali, A.N.2
Kramers, C.3
Harmark, L.V.4
Burger, D.M.5
Verhoeven, W.M.6
-
2
-
-
84890527992
-
The Concise Guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels. Br J Pharmacol 170: 1582-1606.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1582-1606
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
4
-
-
84924934879
-
AT-1001: Pharmacological profile at rat and human a3B4 and a4B2 nicotinic receptors
-
Poster # 224.26-Su
-
Bowman Dalley C, Lewin A, Tuan E, Al-Muhtasib N, Tran T, Gao Y, et al. (2013). AT-1001: pharmacological profile at rat and human a3B4 and a4B2 nicotinic receptors. Neuroscience 2013. Poster # 224.26-Su.
-
(2013)
Neuroscience
, vol.2013
-
-
Bowman Dalley, C.1
Lewin, A.2
Tuan, E.3
Al-Muhtasib, N.4
Tran, T.5
Gao, Y.6
-
5
-
-
78651407161
-
Partial agonists of the alpha3beta4∗ neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats
-
Chatterjee S, Steensland P, Simms JA, Holgate J, Coe JW, Hurst RS, et al. (2011). Partial agonists of the alpha3beta4∗ neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology 36: 603-615.
-
(2011)
Neuropsychopharmacology
, vol.36
, pp. 603-615
-
-
Chatterjee, S.1
Steensland, P.2
Simms, J.A.3
Holgate, J.4
Coe, J.W.5
Hurst, R.S.6
-
6
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
-
Cheng Y, Prusoff WH, (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
-
(1973)
Biochem Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
7
-
-
81255164797
-
Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats
-
Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, et al. (2012). Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100: 522-529.
-
(2012)
Pharmacol Biochem Behav
, vol.100
, pp. 522-529
-
-
Cippitelli, A.1
Damadzic, R.2
Singley, E.3
Thorsell, A.4
Ciccocioppo, R.5
Eskay, R.L.6
-
8
-
-
0033988388
-
Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice
-
Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM, (1999). Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl) 147: 25-26.
-
(1999)
Psychopharmacology (Berl)
, vol.147
, pp. 25-26
-
-
Epping-Jordan, M.P.1
Picciotto, M.R.2
Changeux, J.P.3
Pich, E.M.4
-
9
-
-
84891929233
-
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial
-
Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, et al. (2014). Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA 311: 145-154.
-
(2014)
JAMA
, vol.311
, pp. 145-154
-
-
Evins, A.E.1
Cather, C.2
Pratt, S.A.3
Pachas, G.N.4
Hoeppner, S.S.5
Goff, D.C.6
-
10
-
-
0344490327
-
Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function
-
Fitch RW, Xiao Y, Kellar KJ, Daly JW, (2003). Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function. Proc Natl Acad Sci U S A 100: 4909-4914.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 4909-4914
-
-
Fitch, R.W.1
Xiao, Y.2
Kellar, K.J.3
Daly, J.W.4
-
11
-
-
77953563060
-
Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction
-
Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B, (2010). Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology 35: 1751-1760.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 1751-1760
-
-
Forget, B.1
Wertheim, C.2
Mascia, P.3
Pushparaj, A.4
Goldberg, S.R.5
Le Foll, B.6
-
12
-
-
79953246461
-
Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake
-
Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ, (2011). Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601.
-
(2011)
Nature
, vol.471
, pp. 597-601
-
-
Fowler, C.D.1
Lu, Q.2
Johnson, P.M.3
Marks, M.J.4
Kenny, P.J.5
-
13
-
-
79955658475
-
Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula
-
Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, et al. (2011). Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula. Neuron 70: 522-535.
-
(2011)
Neuron
, vol.70
, pp. 522-535
-
-
Frahm, S.1
Slimak, M.A.2
Ferrarese, L.3
Santos-Torres, J.4
Antolin-Fontes, B.5
Auer, S.6
-
14
-
-
52249093734
-
Tobacco smoking cessation management: Integrating varenicline in current practice
-
Galanti LM, (2008). Tobacco smoking cessation management: integrating varenicline in current practice. Vasc Health Risk Manag 4: 837-845.
-
(2008)
Vasc Health Risk Manag
, vol.4
, pp. 837-845
-
-
Galanti, L.M.1
-
15
-
-
84856255709
-
Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
-
Gamaleddin I, Zvonok A, Makriyannis A, Goldberg SR, Le Foll B, (2012). Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking. PLoS ONE 7: e29900.
-
(2012)
PLoS ONE
, vol.7
, pp. e29900
-
-
Gamaleddin, I.1
Zvonok, A.2
Makriyannis, A.3
Goldberg, S.R.4
Le Foll, B.5
-
16
-
-
79952485903
-
Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
-
George O, Lloyd A, Carroll FI, Damaj MI, Koob GF, (2011). Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl) 213: 715-722.
-
(2011)
Psychopharmacology (Berl)
, vol.213
, pp. 715-722
-
-
George, O.1
Lloyd, A.2
Carroll, F.I.3
Damaj, M.I.4
Koob, G.F.5
-
17
-
-
84904252940
-
Nicotine vapor inhalation escalates nicotine self-administration
-
Gilpin NW, Whitaker AM, Baynes B, Abdel AY, Weil MT, George O, (2014). Nicotine vapor inhalation escalates nicotine self-administration. Addict Biol 19: 587-592.
-
(2014)
Addict Biol
, vol.19
, pp. 587-592
-
-
Gilpin, N.W.1
Whitaker, A.M.2
Baynes, B.3
Abdel, A.Y.4
Weil, M.T.5
George, O.6
-
18
-
-
0033928656
-
Development of novel medications for drug addiction. The legacy of an African shrub
-
Glick SD, Maisonneuve IM, (2000). Development of novel medications for drug addiction. The legacy of an African shrub. Ann N Y Acad Sci 909: 88-103.
-
(2000)
Ann N y Acad Sci
, vol.909
, pp. 88-103
-
-
Glick, S.D.1
Maisonneuve, I.M.2
-
19
-
-
77951006621
-
Nicotinic acetylcholine receptors in the mesolimbic pathway: Primary role of ventral tegmental area alpha6beta2∗ receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement
-
Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, et al. (2010). Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2∗ receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30: 5311-5325.
-
(2010)
J Neurosci
, vol.30
, pp. 5311-5325
-
-
Gotti, C.1
Guiducci, S.2
Tedesco, V.3
Corbioli, S.4
Zanetti, L.5
Moretti, M.6
-
20
-
-
84879463027
-
Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat
-
de Guglielmo G, Cippitelli A, Somaini L, Gerra G, Li H, Stopponi S, et al. (2013). Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict Biol 18: 644-653.
-
(2013)
Addict Biol
, vol.18
, pp. 644-653
-
-
De Guglielmo, G.1
Cippitelli, A.2
Somaini, L.3
Gerra, G.4
Li, H.5
Stopponi, S.6
-
21
-
-
33745611449
-
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial
-
Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296: 56-63.
-
(2006)
JAMA
, vol.296
, pp. 56-63
-
-
Jorenby, D.E.1
Hays, J.T.2
Rigotti, N.A.3
Azoulay, S.4
Watsky, E.J.5
Williams, K.E.6
-
22
-
-
0021808471
-
The quantification of relative efficacy of agonists
-
Kenakin TP, (1985). The quantification of relative efficacy of agonists. J Pharmacol Methods 13: 281-308.
-
(1985)
J Pharmacol Methods
, vol.13
, pp. 281-308
-
-
Kenakin, T.P.1
-
23
-
-
84862860563
-
Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage
-
Khroyan TV, Zhang J, Yang L, Zou B, Xie J, Pascual C, et al. (2012). Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage. Clin Exp Pharmacol Physiol 39: 614-622.
-
(2012)
Clin Exp Pharmacol Physiol
, vol.39
, pp. 614-622
-
-
Khroyan, T.V.1
Zhang, J.2
Yang, L.3
Zou, B.4
Xie, J.5
Pascual, C.6
-
24
-
-
77954326944
-
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
-
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1577-1579
-
-
Kilkenny, C.1
Browne, W.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
25
-
-
77649232027
-
Coadministration of intravenous nicotine and oral alcohol in rats
-
Le AD, Lo S, Harding S, Juzytsch W, Marinelli PW, Funk D, (2010). Coadministration of intravenous nicotine and oral alcohol in rats. Psychopharmacology (Berl) 208: 475-486.
-
(2010)
Psychopharmacology (Berl)
, vol.208
, pp. 475-486
-
-
Le, A.D.1
Lo, S.2
Harding, S.3
Juzytsch, W.4
Marinelli, P.W.5
Funk, D.6
-
26
-
-
84871526073
-
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used
-
Le Foll B, Chakraborty-Chatterjee M, Lev-Ran S, Barnes C, Pushparaj A, Gamaleddin I, et al. (2012). Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. Int J Neuropsychopharmacol 15: 1265-1274.
-
(2012)
Int J Neuropsychopharmacol
, vol.15
, pp. 1265-1274
-
-
Le Foll, B.1
Chakraborty-Chatterjee, M.2
Lev-Ran, S.3
Barnes, C.4
Pushparaj, A.5
Gamaleddin, I.6
-
27
-
-
77249132728
-
Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats
-
Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, et al. (2010). Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther 332: 933-939.
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 933-939
-
-
Levin, E.D.1
Rezvani, A.H.2
Xiao, Y.3
Slade, S.4
Cauley, M.5
Wells, C.6
-
28
-
-
0043199750
-
Anti-addictive actions of an iboga alkaloid congener: A novel mechanism for a novel treatment
-
Maisonneuve IM, Glick SD, (2003). Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 75: 607-618.
-
(2003)
Pharmacol Biochem Behav
, vol.75
, pp. 607-618
-
-
Maisonneuve, I.M.1
Glick, S.D.2
-
29
-
-
0036312108
-
Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice
-
Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC, (2002). Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. J Neurochem 81: 1102-1115.
-
(2002)
J Neurochem
, vol.81
, pp. 1102-1115
-
-
Marks, M.J.1
Whiteaker, P.2
Grady, S.R.3
Picciotto, M.R.4
McIntosh, J.M.5
Collins, A.C.6
-
30
-
-
77954331629
-
Guidelines for reporting experiments involving animals: The ARRIVE guidelines
-
McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1573-1576
-
-
McGrath, J.1
Drummond, G.2
McLachlan, E.3
Kilkenny, C.4
Wainwright, C.5
-
31
-
-
33747598710
-
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors
-
Mihalak KB, Carroll FI, Luetje CW, (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70: 801-805.
-
(2006)
Mol Pharmacol
, vol.70
, pp. 801-805
-
-
Mihalak, K.B.1
Carroll, F.I.2
Luetje, C.W.3
-
32
-
-
77649238532
-
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
-
O'Connor EC, Parker D, Rollema H, Mead AN, (2010). The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 208: 365-376.
-
(2010)
Psychopharmacology (Berl)
, vol.208
, pp. 365-376
-
-
O'Connor, E.C.1
Parker, D.2
Rollema, H.3
Mead, A.N.4
-
33
-
-
78649499544
-
The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats
-
Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, et al. (2010). The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. Prog Neuropsychopharmacol Biol Psychiatry 34: 1455-1464.
-
(2010)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.34
, pp. 1455-1464
-
-
Paterson, N.E.1
Min, W.2
Hackett, A.3
Lowe, D.4
Hanania, T.5
Caldarone, B.6
-
34
-
-
84891791940
-
The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
-
NC-IUPHAR
-
Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-1106.
-
(2014)
Nucl. Acids Res.
, vol.42
, Issue.DATABASE ISSUE
, pp. D1098-D1106
-
-
Pawson, A.J.1
Sharman, J.L.2
Benson, H.E.3
Faccenda, E.4
Alexander, S.P.5
Buneman, O.P.6
-
35
-
-
0036325126
-
Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography
-
Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ, (2002). Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468-481.
-
(2002)
J Neurochem
, vol.82
, pp. 468-481
-
-
Perry, D.C.1
Xiao, Y.2
Nguyen, H.N.3
Musachio, J.L.4
Davila-Garcia, M.I.5
Kellar, K.J.6
-
36
-
-
34250771613
-
Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain
-
Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, Kellar KJ, (2007). Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322: 306-315.
-
(2007)
J Pharmacol Exp Ther
, vol.322
, pp. 306-315
-
-
Perry, D.C.1
Mao, D.2
Gold, A.B.3
McIntosh, J.M.4
Pezzullo, J.C.5
Kellar, K.J.6
-
37
-
-
0032495515
-
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine
-
Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
-
(1998)
Nature
, vol.391
, pp. 173-177
-
-
Picciotto, M.R.1
Zoli, M.2
Rimondini, R.3
Lena, C.4
Marubio, L.M.5
Pich, E.M.6
-
38
-
-
58149385076
-
Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration
-
Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, et al. (2008). Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327.
-
(2008)
J Neurosci
, vol.28
, pp. 12318-12327
-
-
Pons, S.1
Fattore, L.2
Cossu, G.3
Tolu, S.4
Porcu, E.5
McIntosh, J.M.6
-
39
-
-
0029980944
-
Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy
-
Richardson NR, Roberts DC, (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
-
(1996)
J Neurosci Methods
, vol.66
, pp. 1-11
-
-
Richardson, N.R.1
Roberts, D.C.2
-
40
-
-
33846858426
-
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
-
Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, et al. (2007). Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52: 985-994.
-
(2007)
Neuropharmacology
, vol.52
, pp. 985-994
-
-
Rollema, H.1
Chambers, L.K.2
Coe, J.W.3
Glowa, J.4
Hurst, R.S.5
Lebel, L.A.6
-
41
-
-
34547630911
-
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
-
Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE, (2007). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104: 12518-12523.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 12518-12523
-
-
Steensland, P.1
Simms, J.A.2
Holgate, J.3
Richards, J.K.4
Bartlett, S.E.5
-
42
-
-
8344245466
-
Nicotine activation of alpha4∗ receptors: Sufficient for reward, tolerance, and sensitization
-
Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al. (2004). Nicotine activation of alpha4∗ receptors: sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032.
-
(2004)
Science
, vol.306
, pp. 1029-1032
-
-
Tapper, A.R.1
McKinney, S.L.2
Nashmi, R.3
Schwarz, J.4
Deshpande, P.5
Labarca, C.6
-
43
-
-
84859742106
-
AT-1001: A high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats
-
Toll L, Zaveri NT, Polgar WE, Jiang F, Khroyan TV, Zhou W, et al. (2012). AT-1001: a high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology 37: 1367-1376.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 1367-1376
-
-
Toll, L.1
Zaveri, N.T.2
Polgar, W.E.3
Jiang, F.4
Khroyan, T.V.5
Zhou, W.6
-
44
-
-
84872003960
-
Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity
-
Vazquez-DeRose J, Stauber G, Khroyan TV, Xie XS, Zaveri NT, Toll L, (2013). Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity. Eur J Pharmacol 699: 200-206.
-
(2013)
Eur J Pharmacol
, vol.699
, pp. 200-206
-
-
Vazquez-Derose, J.1
Stauber, G.2
Khroyan, T.V.3
Xie, X.S.4
Zaveri, N.T.5
Toll, L.6
-
45
-
-
0032985937
-
Blockade of nicotine self-administration with nicotinic antagonists in rats
-
Watkins SS, Epping-Jordan MP, Koob GF, Markou A, (1999). Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav 62: 743-751.
-
(1999)
Pharmacol Biochem Behav
, vol.62
, pp. 743-751
-
-
Watkins, S.S.1
Epping-Jordan, M.P.2
Koob, G.F.3
Markou, A.4
-
46
-
-
84886259723
-
1)(2)(5)I]AT-1012, a new high affinity radioligand for the alpha3beta4 nicotinic acetylcholine receptors
-
Wu J, Perry DC, Bupp JE, Jiang F, Polgar WE, Toll L, et al. (2014). 1)(2)(5)I]AT-1012, a new high affinity radioligand for the alpha3beta4 nicotinic acetylcholine receptors. Neuropharmacology 77: 193-199.
-
(2014)
Neuropharmacology
, vol.77
, pp. 193-199
-
-
Wu, J.1
Perry, D.C.2
Bupp, J.E.3
Jiang, F.4
Polgar, W.E.5
Toll, L.6
-
47
-
-
84924937479
-
Functional characterization of AT-1001, an alpha3beta4 nicotinic acetylcholine receptor (nAChR) ligand, at human alpha3beta4 and alpha4beta2 nAChR
-
pii: ntu170. [Epub ahead of print]
-
Zaveri NT, Bertrand S, Yasuda D, Bertrand D, (2014). Functional characterization of AT-1001, an alpha3beta4 nicotinic acetylcholine receptor (nAChR) ligand, at human alpha3beta4 and alpha4beta2 nAChR. Nicotine Tob Res pii: ntu170. [Epub ahead of print].
-
(2014)
Nicotine Tob Res
-
-
Zaveri, N.T.1
Bertrand, S.2
Yasuda, D.3
Bertrand, D.4
|